Perpetual Ltd boosted its position in CTS Co. (NYSE:CTS – Free Report) by 88.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 8,501 shares of the electronics maker’s stock after acquiring an additional 3,991 shares during the quarter. Perpetual Ltd’s holdings in CTS were worth $448,000 at the end of the most recent quarter.
A number of other institutional investors also recently added to or reduced their stakes in the company. GAMMA Investing LLC increased its position in shares of CTS by 132.5% in the 3rd quarter. GAMMA Investing LLC now owns 586 shares of the electronics maker’s stock valued at $28,000 after purchasing an additional 334 shares during the last quarter. Canada Pension Plan Investment Board purchased a new stake in CTS during the 2nd quarter worth about $41,000. Quest Partners LLC acquired a new position in shares of CTS during the 3rd quarter worth about $92,000. Summit Trail Advisors LLC purchased a new position in shares of CTS in the 2nd quarter valued at about $214,000. Finally, Sei Investments Co. acquired a new stake in shares of CTS during the 2nd quarter worth about $263,000. Hedge funds and other institutional investors own 96.87% of the company’s stock.
Insider Buying and Selling at CTS
In related news, CEO Kieran M. O’sullivan sold 6,690 shares of the company’s stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $55.83, for a total value of $373,502.70. Following the sale, the chief executive officer now owns 375,643 shares of the company’s stock, valued at approximately $20,972,148.69. This represents a 1.75 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In the last three months, insiders sold 59,956 shares of company stock worth $3,331,185. 2.30% of the stock is owned by corporate insiders.
Wall Street Analyst Weigh In
Read Our Latest Stock Report on CTS
CTS Stock Up 0.2 %
CTS stock opened at $52.97 on Thursday. The stock’s 50 day moving average price is $53.55 and its 200 day moving average price is $50.65. The company has a market cap of $1.60 billion, a PE ratio of 27.30 and a beta of 0.60. The company has a debt-to-equity ratio of 0.19, a current ratio of 2.46 and a quick ratio of 1.91. CTS Co. has a 1-year low of $40.92 and a 1-year high of $59.68.
CTS (NYSE:CTS – Get Free Report) last posted its quarterly earnings results on Tuesday, October 29th. The electronics maker reported $0.63 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.57 by $0.06. CTS had a net margin of 11.66% and a return on equity of 12.39%. The company had revenue of $132.42 million during the quarter. During the same quarter in the previous year, the business posted $0.54 earnings per share. On average, sell-side analysts predict that CTS Co. will post 2.15 EPS for the current fiscal year.
CTS Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be paid a $0.04 dividend. The ex-dividend date is Friday, December 27th. This represents a $0.16 dividend on an annualized basis and a yield of 0.30%. CTS’s payout ratio is 8.25%.
CTS Company Profile
CTS Corporation manufactures and sells sensors, actuators, and connectivity components in North America, Europe, and Asia. The company provides encoders, rotary position sensors, slide potentiometers, industrial and commercial rotary potentiometers. It also provides non-contacting, and contacting pedals; and eBrake pedals.
See Also
- Five stocks we like better than CTS
- Dividend Capture Strategy: What You Need to Know
- Oracle Announces Game-Changing News for the AI Industry
- Basic Materials Stocks Investing
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Receive News & Ratings for CTS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CTS and related companies with MarketBeat.com's FREE daily email newsletter.